Connect
MJA
MJA

Megadose therapy for vitamin D deficiency

Peter R Ebeling
Med J Aust 2005; 183 (1): . || doi: 10.5694/j.1326-5377.2005.tb06875.x
Published online: 4 July 2005

Treating the paradox of an important emerging public health problem

The international perception of bronzed Australians inhabiting a “sunburnt country” is under threat. Most Australians, including children, now sensibly avoid excessive sun exposure to reduce the risk of skin cancer. However, other Australians, particularly those who are older, disabled or institutionalised often do not receive even modest levels of sunlight exposure. This has led to the paradox of vitamin D deficiency emerging as a public health issue in sunny Australia.


  • Departments of Diabetes and Endocrinology and Medicine, University of Melbourne, Royal Melbourne Hospital, Melbourne, VIC.


Correspondence: peter.ebeling@mh.org.au

  • 1. Chatfield S, Ebeling PR. Osteoporosis prevention and treatment: the importance of vitamin D. Mod Med 2005; 6: 16-32.
  • 2. Working Group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia and Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005; 182: 281-285. <eMJA full text>
  • 3. Pasco JA, Henry MJ, Nicholson GC, et al. Vitamin D status of women in the Geelong Osteoporosis Study: association with diet and casual exposure to sunlight. Med J Aust 2001; 175: 401-405.
  • 4. McGrath JJ, Kimlin MG, Saha S, et al. Vitamin D insufficiency in south-east Queensland. Med J Aust 2001; 174: 150-151.
  • 5. Frame B, Parfitt AM. Osteomalacia: current concepts. Ann Intern Med 1978; 89: 966-982.
  • 6. Holick MF, Siris ES, Binkley N, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005; 90: 3215-3224. Epub 2005 Mar 29.
  • 7. Peter R, Mishra V, Fraser WD. Severe hypocalcaemia after being given intravenous bisphosphonate. BMJ 2004; 328: 335-336.
  • 8. Maclsaac RJ, Seeman E, Jerums G. Seizures after alendronate. J R Soc Med 2002; 95: 615-616.
  • 9. Diamond TH, Ho KWK, Rohl PG, Meerkin M. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety. Med J Aust 2005; 183: 10-12. <MJA full text>
  • 10. Anderson FH, Smith HE, Raphael HM, et al. Effect of annual intramuscular vitamin D supplementation on fracture risk in 9440 community living older people: the Wessex Fracture Prevention Trial [abstract]. J Bone Miner Res 2004; 19(Suppl 1): Abstract no. 1220.
  • 11. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992; 327: 1637-1642.
  • 12. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age and older. N Engl J Med 1997; 337: 670-676.
  • 13. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: a randomised double blind controlled trial. BMJ 2003; 326: 469-475.
  • 14. The RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005; 365: 1621-1628.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.